Insight Genetics specializes in the discovery, development, and commercialization of molecular diagnostics that detect specific cancer biomarkers in triple negative breast cancer and lung cancer, with a portfolio of assays that have applications in translational research, clinical diagnostics, and drug discovery. Their innovative platform technology for assay development enables personalized cancer care and improved patient outcomes.